A Simulation study of physiological factors affecting pharmacokinetic behaviour of organic solvent
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
| Tag | 1 | 2 | Value |
|---|---|---|---|
| LDR | 00000nab a2200000 i 4500 | ||
| 001 | MAP20071016945 | ||
| 003 | MAP | ||
| 005 | 20080418114839.0 | ||
| 007 | hzruuu---uuuu | ||
| 008 | 940124e19910501gbr|||| | |00010|eng d | ||
| 035 | $a6800002876 | ||
| 040 | $aMAP$bspa | ||
| 084 | $a873 | ||
| 245 | 1 | 2 | $aA Simulation study of physiological factors affecting pharmacokinetic behaviour of organic solvent$cA. Sato... [et al.] |
| 520 | $aThis paper discusses how physiological factors may influence the pharmacokinetic behaviour of inhaled organic solvent vapours, especially in relation to monitoring of biological exposure. To illustrate the discussion a computer based physiological pharmacokinetic model was used describing quantitatively the influence of body size, body fat content, and sex on the pharmacokienetic behaviour of trichloroethylene. Body build (body weight and body fat content), also affected the pharmacokinetic behaviour of this solvent | ||
| 650 | 1 | 1 | $0MAPA20080576615$aMedicina laboral |
| 650 | 1 | 1 | $0MAPA20080605278$aContaminantes químicos |
| 650 | 1 | 1 | $0MAPA20080610579$aEnfermedades pulmonares |
| 650 | 1 | 1 | $0MAPA20080619480$aEnfermedades profesionales |
| 650 | 1 | 1 | $0MAPA20080554392$aFisiología |
| 650 | 1 | 1 | $0MAPA20080600976$aDisolventes orgánicos |
| 650 | 1 | 1 | $0MAPA20080574215$aTricloroetileno |
| 650 | 1 | 1 | $0MAPA20080565541$aEpidemiología |
| 650 | 1 | 1 | $0MAPA20080583163$aVapores orgánicos |
| 650 | 1 | 1 | $0MAPA20080578824$aAnálisis clínicos |
| 700 | 1 | $0MAPA20080016975$aSato, Akio | |
| 740 | 0 | $aBritish journal of industrial medicine | |
| 773 | 0 | $tBritish journal of industrial medicine$dLondon and Margate$gnº 5, May 1991 ; p. 342-347 |